| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/29/2002 | WO2002066620A2 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system |
| 08/29/2002 | WO2002066512A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | WO2002066481A1 Pyrimidine derivatives for inhibition of cell-proliferation |
| 08/29/2002 | WO2002066470A1 Substituted alkylamine derivatives and methods of use |
| 08/29/2002 | WO2002066454A1 Chromene derivatives |
| 08/29/2002 | WO2002066432A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 08/29/2002 | WO2002066430A1 Tryptase inhibitors |
| 08/29/2002 | WO2002066422A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 08/29/2002 | WO2002066055A1 NOVEL MEDICINAL USE OF α ANTIGEN OR α ANTIGEN GENE |
| 08/29/2002 | WO2002066050A1 Casoase 3 inhibitors |
| 08/29/2002 | WO2002066047A1 Use of $g(g)-gt inhibitors for the treatment of degenerative diseases |
| 08/29/2002 | WO2002066030A1 Medicinal compositions comprising diclofenac and ornoprostil |
| 08/29/2002 | WO2002066023A1 Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications |
| 08/29/2002 | WO2002065978A2 Functional agent for decomposing nicotine and method of preparing the same |
| 08/29/2002 | WO2002065943A2 Ocular tear growth factor-like protein |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002028858A3 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 08/29/2002 | WO2001096547A3 Human kinases |
| 08/29/2002 | WO2001077338A3 Human protein kinases and protein kinase-like enzymes |
| 08/29/2002 | WO2001068053A3 Methods and compositions for treating and preventing posterior segment ophthalmic disorders |
| 08/29/2002 | WO2001000247A9 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 08/29/2002 | WO2000061606A9 Novel human voltage-gated potassium channel |
| 08/29/2002 | WO2000037502A9 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/29/2002 | WO2000034474A9 Growth factor homolog zvegf3 |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120948 Modulating gene expression by regulation of cell proliferation; regulated transgene expression in lymphocytes by selective increase in the number of lymphocytes upon exposure to an antigen |
| 08/29/2002 | US20020120123 Human vascular endothelial growth factor 2 |
| 08/29/2002 | US20020119999 Imidazole dione or one, thione derivatives as antitumor and antiinflammatory agents, also treats cardiovascular disease, nephropathies and retinopathies |
| 08/29/2002 | US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 08/29/2002 | US20020119976 Tetracyclic derivatives, process of preparation and use |
| 08/29/2002 | US20020119974 Administering guanosine cyclic 3',5'-monophosphate; phosphodiesterase inhibitor |
| 08/29/2002 | US20020119967 Autoimmune diseases; administering phosphodiesterases inhibitor |
| 08/29/2002 | US20020119964 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase |
| 08/29/2002 | US20020119961 Bridged piperazine derivatives |
| 08/29/2002 | US20020119956 Using thalidomine |
| 08/29/2002 | US20020119202 For therapy of cancer and other angiogenic-dependent diseases |
| 08/29/2002 | US20020119153 Antibody conjugate formulations for selectively inhibiting VEGF |
| 08/29/2002 | US20020119144 Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
| 08/29/2002 | US20020119141 Using enzyme for the manufacture of a medicament to eliminate corneal scar, opacity, and haze |
| 08/29/2002 | US20020119104 Treatment of mucositis |
| 08/29/2002 | DE10108307A1 Substituierte Propan-1,3-diamin-Derivate Substituted propane-1,3-diamine derivatives |
| 08/29/2002 | CA2443502A1 Use of mycobacterium .alpha. antigen to prevent or treat allergic diseases |
| 08/29/2002 | CA2439193A1 Casoase 3 inhibitors |
| 08/29/2002 | CA2438685A1 Tryptase inhibitors |
| 08/29/2002 | CA2438241A1 Medicinal compositions comprising diclofenac and ornoprostil |
| 08/29/2002 | CA2437977A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 08/29/2002 | CA2432932A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/28/2002 | WO2001064242A1 Drugs for ameliorating retinal function |
| 08/28/2002 | EP1234582A1 Concomitant drugs for treating glaucoma |
| 08/28/2002 | EP1234574A1 Hair growth stimulant |
| 08/28/2002 | EP1234185A2 Pin1 as a marker for abnormal cell growth |
| 08/28/2002 | EP1233975A1 29 human secreted proteins |
| 08/28/2002 | EP1233962A2 Novel heterocyclic compounds and their use as medicines |
| 08/28/2002 | EP1233959A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 08/28/2002 | EP1233951A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 08/28/2002 | EP1233950A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS |
| 08/28/2002 | EP1233786A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 08/28/2002 | EP1233769A1 Novel compounds |
| 08/28/2002 | EP1233765A1 TREATMENT OF EOSINOPHIL ASSOCIATED PATHOLOGIES BY MODULATING PKC-$g(d) ACTIVITY |
| 08/28/2002 | EP1233753A1 Composition and method for treatment of otitis media |
| 08/28/2002 | CN1366524A Sulfonamide derivative as matrix metalloproteinase inhibitor |
| 08/28/2002 | CN1366459A Preventive or therapeutic drugs for various eosinophilia-realated diseases containing chymase inhibitors as active ingredient |
| 08/28/2002 | CN1365976A Process for extracting medicinal component from pueraria root |
| 08/28/2002 | CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 08/28/2002 | CN1089759C Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 08/28/2002 | CN1089603C Liquid medicine for treating diseases of eye, ear, nose and throat |
| 08/28/2002 | CA2401557A1 Medecine for improving retinal functions |
| 08/27/2002 | US6441137 Tie-2 ligands; tie= ?tyrosine kinase with ig (immunoglobulins) and egf (epidermal growth factor) homology domains?; tumor neovascularization |
| 08/27/2002 | US6441035 Administering to a mammal for the treatment of dry eye or other disorders requiring the wetting of the eye a heteroatom such as nitrogen, oxygen or sulfur interrupted hydroxyeicosatetraenoic acid related compounds |
| 08/27/2002 | US6441032 Treating systemic lupis and multiple sclerosis |
| 08/27/2002 | US6441017 Inhibitors of prenyl-protein transferase |
| 08/27/2002 | US6441015 Tetrazole compounds as thyroid receptor ligands |
| 08/27/2002 | US6440973 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 08/27/2002 | US6440968 Use of maduraohtalazine derivatives as inhibitors of proinflammatory cytokines |
| 08/27/2002 | US6440955 Anti-inflammatory agents |
| 08/27/2002 | US6440938 Prevention and/or treatment of allergic conditions |
| 08/27/2002 | US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy |
| 08/22/2002 | WO2002064827A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 08/22/2002 | WO2002064792A2 Molecules for disease detection and treatment |
| 08/22/2002 | WO2002064755A2 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 08/22/2002 | WO2002064599A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064592A1 Tricyclic crf receptor antagonists |
| 08/22/2002 | WO2002064591A2 Carboline derivatives |
| 08/22/2002 | WO2002064590A2 Carboline derivatives |
| 08/22/2002 | WO2002064589A1 Laulimalide derivatives |
| 08/22/2002 | WO2002064584A1 Phthalayinone-piperidino-derivatives as pde4 inhibitors |
| 08/22/2002 | WO2002064572A1 Quinazolines as mmp-13 inhibitors |
| 08/22/2002 | WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064160A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/22/2002 | WO2002064146A1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical |
| 08/22/2002 | WO2002064144A1 Aqueous suspension eyedrops and process for producing the same |
| 08/22/2002 | WO2002064126A2 Method of treating of demyelinating diseases or conditions |
| 08/22/2002 | WO2002064114A1 Novel ophthalmic compositions |
| 08/22/2002 | WO2002064083A2 Synthesis of 3-amino-thalidomide and its enantiomers |
| 08/22/2002 | WO2002045652A3 Tyrosine kinase inhibitors |
| 08/22/2002 | WO2002042280A3 Pyrimidine derivatives |
| 08/22/2002 | WO2002032862A3 Use of p38 inhibitors for the treatment of smoke inhalation |